Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.560
-0.190 (-6.91%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $92.56 million. The enterprise value is $217.12 million.

Market Cap 92.56M
Enterprise Value 217.12M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

ARMP has 36.15 million shares outstanding. The number of shares has increased by 0.22% in one year.

Shares Outstanding 36.15M
Shares Change (YoY) +0.22%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 70.28%
Owned by Institutions (%) 3.93%
Float 11.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.70
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 46.21
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.38

Current Ratio 0.38
Quick Ratio 0.41
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -16.90

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.60%
Return on Capital (ROIC) -35.70%
Revenue Per Employee $71,197
Profits Per Employee -$1.21M
Employee Count 66
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +120.69% in the last 52 weeks. The beta is 0.83, so ARMP's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change +120.69%
50-Day Moving Average 2.70
200-Day Moving Average 2.93
Relative Strength Index (RSI) 42.27
Average Volume (20 Days) 10,897

Short Selling Information

The latest short interest is 894, so 0.00% of the outstanding shares have been sold short.

Short Interest 894
Short Previous Month 767
Short % of Shares Out 0.00%
Short % of Float 0.01%
Short Ratio (days to cover) 0.06

Income Statement

In the last 12 months, ARMP had revenue of $4.70 million and -$79.58 million in losses. Loss per share was -$2.27.

Revenue 4.70M
Gross Profit 4.70M
Operating Income -39.77M
Pretax Income -79.58M
Net Income -79.58M
EBITDA -74.07M
EBIT -75.13M
Loss Per Share -$2.27
Full Income Statement

Balance Sheet

The company has $43.34 million in cash and $167.91 million in debt, giving a net cash position of -$124.57 million or -$3.45 per share.

Cash & Cash Equivalents 43.34M
Total Debt 167.91M
Net Cash -124.57M
Net Cash Per Share -$3.45
Equity (Book Value) -56.51M
Book Value Per Share -1.56
Working Capital -68.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.44 million and capital expenditures -$6.37 million, giving a free cash flow of -$46.81 million.

Operating Cash Flow -40.44M
Capital Expenditures -6.37M
Free Cash Flow -46.81M
FCF Per Share -$1.30
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -846.39% and -1,693.47%.

Gross Margin 100.00%
Operating Margin -846.39%
Pretax Margin -1,693.47%
Profit Margin -1,693.47%
EBITDA Margin -1,576.31%
EBIT Margin -1,598.85%
FCF Margin -996.19%

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.22%
Shareholder Yield -0.22%
Earnings Yield -85.98%
FCF Yield -50.58%

Analyst Forecast

The average price target for ARMP is $7.00, which is 173.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 173.44%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 66.19%
EPS Growth Forecast (5Y) -45.50%
Stock Forecasts

Stock Splits

The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:14.

Last Split Date May 10, 2019
Split Type Reverse
Split Ratio 1:14

Scores

ARMP has an Altman Z-Score of -6.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.27
Piotroski F-Score 1